# Baim Institute for Clinical Research

Organization · id `cardio:org-baim-institute-for-clinical-research` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01va8fr66](<https://ror.org/01va8fr66>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01va8fr66 by an exact name.

## The registry's words

- Sponsor name: Baim Institute for Clinical Research
- Sponsor class: OTHER
- ROR name: Baim Institute for Clinical Research

## Connected pages

- Sponsors: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (`cardio:ct-nct01233518`)
- Sponsors: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (`cardio:ct-nct02389946`)
- Sponsors: Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation (`cardio:ct-nct02608099`)
- Sponsors: Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (`cardio:ct-nct03423511`)
- Sponsors: NORM-HF Pivotal Study (`cardio:ct-nct07574593`)
- Sponsors: Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC) (`cardio:ct-nct07811427`)
- Sponsors: This Will be a Randomized Comparison of the Proteomic Effects of Vicadrostat/Empagliflozin Versus Empagliflozin and Versus Empagliflozin/Spironolactone in Heart Failure Patients With Preserved Ejection Fraction (`cardio:ct-nct07857772`)

## Provenance

Content hash: d78319e22e4ecdfaedcce5e16504afc6ad2aecf7a3f338ed55c1e326736b91b9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
